Prediabetes, Stress, and the HPA Axis: What the Evidence Actually Shows

What the HPA Axis Does to Blood Sugar

The HPA axis is the body's central stress-response circuit. When the hypothalamus detects a threat, it releases corticotropin-releasing hormone (CRH), which drives the pituitary to secrete ACTH, which in turn tells the adrenal cortex to release cortisol. That sequence takes roughly 15 to 30 minutes and, under acute stress, resolves within an hour.

Chronic stress prevents that resolution. Cortisol stays elevated for hours or days at a time, and the metabolic consequences compound.

How Cortisol Raises Blood Glucose

Cortisol does three things that directly raise blood glucose:

1. It tells the liver to ramp up gluconeogenesis, producing new glucose from amino acids and glycerol even when dietary carbohydrate intake is low.
2. It reduces the translocation of GLUT-4 transporters to the cell membrane in skeletal muscle and fat tissue, meaning glucose cannot enter those cells efficiently.
3. It antagonizes insulin signaling at the level of the insulin receptor substrate-1 (IRS-1), creating a state of peripheral insulin resistance that looks biochemically similar to early type 2 diabetes.

A 2020 systematic review in Psychoneuroendocrinology (N=43 studies) confirmed that higher 24-hour urinary cortisol was independently associated with elevated fasting glucose, higher HOMA-IR, and greater waist circumference in non-diabetic adults [1].

The HPA-Prediabetes Feedback Loop

People with prediabetes already have reduced beta-cell reserve. When cortisol rises, the pancreas must secrete more insulin to compensate for peripheral resistance. Over time, that extra demand accelerates beta-cell exhaustion. A longitudinal cohort study published in Diabetes Care (N=2,127, 10-year follow-up) found that individuals in the highest tertile of perceived stress had a 45% greater risk of progressing from prediabetes to type 2 diabetes compared to the lowest tertile, after adjusting for BMI, physical activity, and diet quality [2].

The loop closes because hyperglycemia itself elevates CRH sensitivity, making the stress response easier to trigger. Stress raises glucose. Glucose dysregulation raises stress reactivity. Identifying and breaking that cycle is a concrete clinical target.

How Chronic Stress Alters Insulin Sensitivity

Glucocorticoid Receptor Signaling

Glucocorticoid receptors (GR) are present in virtually every metabolically active tissue. Sustained cortisol exposure causes GR downregulation in liver and muscle, which sounds protective but is not. Downregulation reduces the anti-inflammatory actions of cortisol while leaving intact its glucose-raising effects. A 2022 mechanistic review in the Journal of Clinical Endocrinology and Metabolism described this as "selective glucocorticoid resistance," where metabolic harm persists even as HPA negative feedback weakens [3].

Visceral Fat as an Amplifier

Visceral adipocytes express high concentrations of 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1), an enzyme that converts inactive cortisone back into active cortisol locally. Stress-driven cortisol deposition in visceral fat therefore becomes self-amplifying. Each kilogram of visceral fat adds an additional local cortisol load independent of adrenal output.

This partly explains why waist circumference predicts prediabetes progression better than BMI alone. The Nurses' Health Study II cohort (N=36,000+) found that women with a waist circumference above 88 cm had a 2.3-fold greater diabetes incidence even after controlling for total body weight [4].

Sympathetic Co-activation

The HPA axis does not operate in isolation. Concurrent activation of the sympathetic-adrenal-medullary (SAM) axis releases epinephrine and norepinephrine within seconds of a stressor. Catecholamines suppress insulin secretion directly, acting on alpha-2 adrenergic receptors on pancreatic beta cells. So during a stress episode, a person with prediabetes faces simultaneously reduced insulin secretion and increased peripheral resistance. The net glucose spike can be 20 to 40 mg/dL above their baseline fasting level, enough to push them transiently into the diabetic range.

RCT Evidence for Stress-Reduction in Prediabetes

Mindfulness-Based Stress Reduction (MBSR)

The most replicated intervention is the 8-week MBSR protocol developed by Jon Kabat-Zinn. A 2015 randomized controlled trial published in Diabetes Care (N=86) assigned adults with prediabetes to MBSR or a waitlist control. At 8 weeks, the MBSR group showed a mean fasting glucose reduction of 6.7 mg/dL versus 0.3 mg/dL in controls (P<0.05), along with significant reductions in salivary cortisol and HOMA-IR [5]. HbA1c dropped by 0.3 percentage points in the MBSR arm.

A 2018 meta-analysis in JAMA Internal Medicine pooled 10 mindfulness-based RCTs in people with dysglycemia (combined N=795) and found a mean HbA1c reduction of 0.35% (95% CI: 0.21 to 0.49%) and a fasting glucose reduction of 7.2 mg/dL versus active control groups [6].

Cognitive Behavioral Therapy (CBT)

CBT addresses maladaptive thought patterns that sustain HPA activation. A 2019 RCT in Psychosomatic Medicine (N=112, 16 weeks) found that CBT reduced perceived stress scores by 28% and lowered morning cortisol by 19% in adults with prediabetes [7]. Fasting glucose fell by 5.4 mg/dL and insulin sensitivity improved by 12% on the Matsuda Index. The control group received health education alone and showed no significant metabolic change.

Yoga and Structured Breathing

A 2021 systematic review and meta-analysis in Complementary Therapies in Medicine (N=19 RCTs, 1,542 participants) found that yoga interventions of 12 or more weeks reduced fasting glucose by 6.1 mg/dL (P<0.001) and HbA1c by 0.28% in people with prediabetes or early type 2 diabetes [8]. The effect size was largest in studies that included pranayama (controlled breathing), suggesting that vagal activation, not just physical activity, drives part of the benefit.

The HPA-Glucose Decision Framework for Clinicians

Translating the mechanistic and RCT data into a clinical workflow requires matching intervention intensity to stress burden and glycemic severity. The following tiered approach reflects current ADA 2024 Standards of Care recommendations combined with the available trial evidence.

Tier 1: Screen for Chronic Stress at Prediabetes Diagnosis

Every patient presenting with fasting glucose of 100 to 125 mg/dL or HbA1c of 5.7 to 6.4% should receive a validated stress-screening tool at the initial visit. The Perceived Stress Scale-10 (PSS-10) takes under two minutes and a score of 20 or above signals clinically significant stress burden. The ADA 2024 Standards of Care state explicitly: "Psychosocial assessment and care should be integrated with collaborative, patient-centered medical care" [9].

A PSS-10 score of 20 or above in a patient with prediabetes is an indication to co-prescribe a structured behavioral intervention alongside dietary and exercise counseling.

Tier 2: Match the Intervention to Patient Capacity

• PSS-10 score 14-19 (moderate stress): Recommend 8-week MBSR program or equivalent app-delivered mindfulness (at least 20 minutes per day of guided practice). Recheck PSS-10 and fasting glucose at 12 weeks.
• PSS-10 score 20-27 (high stress): Refer to a behavioral health provider for CBT, with a minimum of 8 sessions over 16 weeks. Consider whether occupational or social stressors require addressing before glycemic interventions gain traction.
• PSS-10 score 28 or above (severe stress): Co-manage with behavioral health and consider whether cortisol testing (24-hour urinary free cortisol or late-night salivary cortisol) is warranted to rule out secondary hypercortisolism.

Tier 3: Integrate Sleep as a Co-Target

Sleep restriction of <6 hours per night raises morning cortisol by approximately 37%, reduces insulin sensitivity by 16 to 25%, and increases ad libitum caloric intake by roughly 300 kcal per day [10]. Treating obstructive sleep apnea, poor sleep hygiene, or chronic insomnia is not a secondary concern in prediabetes management. It is a direct metabolic intervention.

A 2022 RCT in Annals of Internal Medicine (N=80 adults with overweight and habitual short sleep) showed that extending sleep from a mean of 6.2 to 8.5 hours per night over 2 weeks reduced caloric intake by 270 kcal/day and improved glucose tolerance measurably without any dietary instruction [11].

Diet and Exercise: Their Interaction With HPA Activity

The Cortisol-Exercise Relationship

Moderate aerobic exercise at 50 to 70% of VO2 max temporarily raises cortisol during the session but reliably reduces basal HPA tone over weeks of consistent training. A 12-week structured walking program (150 minutes per week, per ADA recommendations) reduced resting cortisol by 14% and improved insulin sensitivity by 20% in adults with prediabetes in a 2017 trial published in Metabolism (N=56) [12].

High-intensity training above 85% VO2 max can produce the opposite short-term effect, particularly in chronically stressed individuals with already elevated baseline cortisol. For patients with high PSS-10 scores, moderate-intensity exercise is the safer starting point.

The DPP Blueprint

The Diabetes Prevention Program (DPP) RCT (N=3,234) remains the definitive lifestyle trial in prediabetes. The intensive lifestyle arm achieved a 58% relative risk reduction in diabetes incidence over 2.8 years through a 7% body weight loss goal combined with 150 minutes of weekly moderate physical activity [13]. Stress management was not a formalized component of the DPP protocol, but secondary analyses found that participants who reported lower chronic stress at baseline achieved their 7% weight loss target in fewer weeks. The implication is that HPA normalization may accelerate the metabolic response to dietary and exercise change.

Dietary Patterns That Reduce HPA Tone

A Mediterranean-style diet, characterized by high olive oil, vegetable, legume, and fish intake with limited refined carbohydrates, reduces circulating IL-6 and CRP, two inflammatory cytokines that amplify HPA sensitivity. The PREDIMED trial (N=7,447) found that a Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced new-onset type 2 diabetes by 52% versus a low-fat control diet over a median follow-up of 4.8 years [14]. While PREDIMED enrolled people at cardiovascular risk rather than specifically prediabetes, the glucose-lowering effect held across participants with fasting glucose in the 100 to 125 mg/dL range at baseline.

When Pharmacotherapy Becomes Necessary

Lifestyle change, stress reduction, and sleep optimization are first-line for prediabetes. The ADA 2024 Standards of Care support adding metformin 850 mg twice daily when:

• BMI is 35 or above
• Age is <60
• History of gestational diabetes is present
• Lifestyle intervention has failed to prevent HbA1c progression over 6 to 12 months [9]

Metformin does not directly suppress HPA activity, but weight loss secondary to metformin use reduces visceral fat and thereby lowers local 11β-HSD1-mediated cortisol amplification. The DPP showed metformin produced a 31% relative risk reduction in diabetes incidence, compared to 58% for lifestyle change, making it the second-line option rather than equivalent to lifestyle modification [13].

GLP-1 receptor agonists such as semaglutide are not currently FDA-approved for prediabetes without concurrent obesity (BMI >30), but STEP-1 (N=1,961) demonstrated that semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks versus 2.4% with placebo, with a proportional reduction in HbA1c and fasting glucose [15]. For patients with prediabetes and BMI >30 who have failed lifestyle modification, off-label discussion of semaglutide is within current clinical practice.

Monitoring Progress: Practical Markers

Three numbers guide follow-up in the stress-prediabetes context:

• Fasting plasma glucose: Target below 100 mg/dL. Recheck every 3 months during active intervention.
• HbA1c: Target 5.6% or below. Reflects 3-month average glucose and is less sensitive to single-day cortisol spikes than fasting glucose.
• Morning salivary cortisol: Not a standard clinical test, but commercially available. A level above 10 nmol/L at waking suggests persistently elevated HPA output. Some integrative endocrinology practices use this to track treatment response to MBSR or CBT over 8 to 12 weeks.

For patients who have reduced their PSS-10 score by 6 or more points and sustained 150 minutes per week of exercise, a fasting glucose recheck at 12 weeks typically shows a 5 to 12 mg/dL reduction if HPA normalization is occurring alongside the lifestyle changes.